Michael Ohlmeyer Selected Research

Michael Ohlmeyer Research Topics

Disease

11	Neoplasms (Cancer) 04/2022 - 10/2013
5	Inflammation (Inflammations) 08/2023 - 12/2018
4	Chronic Obstructive Pulmonary Disease (COPD) 08/2023 - 05/2009
3	Lung Diseases (Lung Disease) 08/2023 - 12/2018
3	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2020
2	Idiopathic Pulmonary Fibrosis 11/2023 - 08/2023
2	Lung Neoplasms (Lung Cancer) 08/2023 - 01/2018
2	Infections 01/2021 - 04/2013
2	Adenocarcinoma of Lung 01/2019 - 07/2012
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2012
1	Fibrosis (Cirrhosis) 11/2023
1	Emphysema 11/2023
1	Asthma (Bronchial Asthma) 08/2023
1	Hepatoblastoma 06/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Medulloblastoma 01/2023
1	Neuroblastoma 04/2022
1	Peritonitis 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Glioma (Gliomas) 01/2020
1	Hyperhomocysteinemia 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Adenocarcinoma 01/2019
1	Respiratory Hypersensitivity 01/2019
1	Carcinogenesis 01/2018
1	Thyroiditis 02/2016
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 02/2016
1	Thyroid Diseases (Thyroid Disease) 02/2016
1	Thyroid Neoplasms (Thyroid Cancer) 01/2015
1	Melanoma (Melanoma, Malignant) 10/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2013
1	HIV Infections (HIV Infection) 08/2012
1	Autoimmune Diseases (Autoimmune Disease) 08/2010
1	Reticulocytosis 08/2010
1	Rare Diseases (Rare Disease) 07/2010
1	Ulcerative Colitis 05/2009
1	Rheumatoid Arthritis 05/2009

Drug/Important Bio-Agent (IBA)

15	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 11/2023 - 01/2018
8	Phosphotransferases (Kinase)IBA 01/2023 - 06/2017
6	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2023 - 06/2017
4	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 11/2023 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 08/2023 - 04/2013
3	SmokeIBA 08/2023 - 12/2018
2	Serine (L-Serine)FDA Link 08/2023 - 01/2019
2	Threonine (L-Threonine)FDA Link 08/2023 - 01/2019
2	SulfonamidesIBA 06/2023 - 01/2020
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 06/2023 - 06/2017
2	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2023 - 01/2022
2	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 12/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2018 - 07/2012
2	CytokinesIBA 08/2012 - 08/2010
1	Bleomycin (Blenoxane)FDA LinkGeneric 11/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2023
1	HoloenzymesIBA 08/2023
1	Peptide Hydrolases (Proteases)FDA Link 08/2023
1	EnzymesIBA 08/2023
1	Cytostatic AgentsIBA 01/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023
1	Fingolimod Hydrochloride (FTY720)FDA Link 04/2022
1	lestaurtinibIBA 01/2022
1	staurosporine aglycone (K252a)IBA 01/2022
1	StaurosporineIBA 01/2022
1	7-hydroxystaurosporine (UCN 01)IBA 01/2022
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	InflammasomesIBA 01/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2020
1	Cysteine Proteases (Cysteine Protease)IBA 01/2019
1	cathepsin SIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 12/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2018
1	Matrix Metalloproteinases (MMPs)IBA 12/2018
1	Growth Factor ReceptorsIBA 12/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	enzalutamideIBA 01/2018
1	AndrogensIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	AZD 6244IBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 02/2016
1	Arginine (L-Arginine)FDA Link 02/2016
1	Peptides (Polypeptides)IBA 02/2016
1	dibenzazepineIBA 10/2015
1	PhenothiazinesIBA 10/2015
1	DibenzazepinesIBA 10/2015
1	phenothiazineIBA 10/2015
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2015
1	LigandsIBA 01/2015
1	Molecular Probes (Molecular Probe)IBA 01/2015
1	Vesicular Transport Adaptor ProteinsIBA 04/2013
1	Cell Surface ReceptorsIBA 04/2013
1	ChemokinesIBA 08/2012
1	Trifluoperazine (Stelazine)FDA LinkGeneric 07/2012
1	Interferon-gamma (Interferon, gamma)IBA 08/2010
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 08/2010
1	Chemokine ReceptorsIBA 05/2009

Therapy/Procedure

12	Therapeutics 11/2023 - 07/2010
1	Treatment Delay 11/2023
1	Castration 01/2018
1	Aftercare (After-Treatment) 01/2012